(Q40719379)
Statements
Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemia (English)
Spadea A
Petti MC
Fazi P
Vegna ML
Arcese W
Avvisati G
Aloe Spiriti MA
Latagliata R
Meloni G